|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
73,690,000 |
Market
Cap: |
145.91(M) |
Last
Volume: |
576,427 |
Avg
Vol: |
574,861 |
52
Week Range: |
$1.42 - $3.2 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : 4.9 |
Insider 6 Months : 6 |
Insider 3/6 Months : 11.3 |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Stereotaxis designs, manufactures and markets robotic systems, instruments and information systems for the interventional laboratory. Co.'s products include: Genesis RMN System and Niobe System, which enable physicians to complete interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites; Odyssey Solution, which provides an integrated, real-time information solution to manage, control, record and share procedures across networks; and Stereotaxis Imaging Model S x-ray System, which provides an integrated solution for a robotic interventional operating room.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
10,026 |
21,086 |
192,605 |
192,605 |
Total Buy Value |
$19,143 |
$38,166 |
$307,127 |
$307,127 |
Total People Bought |
1 |
1 |
1 |
1 |
Total Buy Transactions |
3 |
4 |
27 |
27 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-08 |
2023-12-06 |
2023-06-07 |
2022-06-07 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Duros Karen Witte |
Sr. VP, Gen. Counsel and Sec. |
|
2017-03-29 |
4 |
D |
$0.55 |
$1,617 |
D/D |
(2,926) |
61,855 |
|
- |
|
Giffin David |
VP, Human Resources |
|
2017-03-29 |
4 |
D |
$0.55 |
$1,617 |
D/D |
(2,926) |
62,512 |
|
- |
|
Brathwaite Paul |
VP Research & Development |
|
2017-03-28 |
4 |
D |
$0.53 |
$1,295 |
D/D |
(2,452) |
42,910 |
|
- |
|
Stammer Martin C |
Chief Financial Officer |
|
2017-03-28 |
4 |
D |
$0.53 |
$3,376 |
D/D |
(6,391) |
112,647 |
|
- |
|
Duros Karen Witte |
Sr. VP, Gen. Counsel and Sec. |
|
2017-03-28 |
4 |
D |
$0.53 |
$1,295 |
D/D |
(2,452) |
64,781 |
|
- |
|
Giffin David |
VP, Human Resources |
|
2017-03-28 |
4 |
D |
$0.53 |
$1,295 |
D/D |
(2,452) |
65,438 |
|
- |
|
Giffin David |
VP, Human Resources |
|
2017-02-08 |
4 |
D |
$0.65 |
$499 |
D/D |
(767) |
67,890 |
|
- |
|
Duros Karen Witte |
Sr. VP, Gen. Counsel & Sec. |
|
2017-02-08 |
4 |
D |
$0.65 |
$499 |
D/D |
(767) |
67,233 |
|
- |
|
Stammer Martin C |
Chief Financial Officer |
|
2017-02-08 |
4 |
D |
$0.65 |
$1,308 |
D/D |
(2,012) |
119,038 |
|
- |
|
Brathwaite Paul |
VP Research & Development |
|
2017-02-08 |
4 |
D |
$0.65 |
$499 |
D/D |
(767) |
45,362 |
|
- |
|
Fischel Nathan |
Director |
|
2017-02-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,372,862 |
|
- |
|
Fischel Nathan |
Director |
|
2017-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
20,000 |
|
- |
|
Menawat Arun Swarup |
Director |
|
2016-12-02 |
4 |
OE |
$0.65 |
$101,035 |
D/D |
155,439 |
175,439 |
|
- |
|
Menawat Arun Swarup |
Director |
|
2016-09-29 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
20,000 |
|
- |
|
Kiani Joe E |
Director |
|
2016-09-29 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
20,000 |
|
- |
|
Fischel David Leo |
Director |
|
2016-09-29 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
20,000 |
|
- |
|
Stammer Martin C |
Chief Financial Officer |
|
2016-08-23 |
4 |
D |
$0.69 |
$457 |
D/D |
(663) |
121,050 |
|
- |
|
Giffin David |
VP, Human Resources |
|
2016-08-23 |
4 |
D |
$0.66 |
$1,342 |
D/D |
(2,033) |
68,657 |
|
- |
|
Cheng Frank |
Senior VP, Marketing and BD |
|
2016-08-23 |
4 |
D |
$0.66 |
$1,525 |
D/D |
(2,311) |
74,885 |
|
- |
|
Duros Karen Witte |
Sr. VP, Gen. Counsel & Sec. |
|
2016-08-23 |
4 |
D |
$0.68 |
$1,374 |
D/D |
(2,021) |
68,000 |
|
- |
|
Brathwaite Paul |
VP Research & Development |
|
2016-08-23 |
4 |
D |
$0.69 |
$950 |
D/D |
(1,377) |
46,129 |
|
- |
|
Keegan Joseph D |
Director |
|
2016-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
51,593 |
|
- |
|
Thomson Euan |
Director |
|
2016-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
60,000 |
|
- |
|
Middleton Fred A |
Director |
|
2016-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
56,810 |
|
- |
|
Prystowsky Eric N |
Director |
|
2016-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
52,593 |
|
- |
|
659 Records found
|
|
Page 8 of 27 |
|
|